Stage specificity of novel growth factor expression during development of proliferative vitreoretinopathy

[1]  B. Kirchhof.  Strategies to influence PVR development , 2004, Graefe's Archive for Clinical and Experimental Ophthalmology.

[2]  G. A. Limb,et al.  Glial cell expression of hepatocyte growth factor in vitreoretinal proliferative disease , 2004, Laboratory Investigation.

[3]  D. Brigstock,et al.  Connective Tissue Growth Factor (CCN2) Induces Adhesion of Rat Activated Hepatic Stellate Cells by Binding of Its C-terminal Domain to Integrin αvβ3 and Heparan Sulfate Proteoglycan* , 2004, Journal of Biological Chemistry.

[4]  Gary R. Grotendorst,et al.  Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[5]  B. Perbal.  CCN proteins: multifunctional signalling regulators , 2004, The Lancet.

[6]  R. Caldwell,et al.  HGF regulation of RPE proliferation in an IL-1beta/retinal hole-induced rabbit model of PVR. , 2002, Molecular vision.

[7]  D. B. Paul,et al.  Ribozyme to proliferating cell nuclear antigen to treat proliferative vitreoretinopathy. , 2002, Investigative ophthalmology & visual science.

[8]  E. Barrón,et al.  Regulation of RPE intercellular junction integrity and function by hepatocyte growth factor. , 2002, Investigative ophthalmology & visual science.

[9]  E. Barrón,et al.  Novel growth factors involved in the pathogenesis of proliferative vitreoretinopathy , 2002, Eye.

[10]  P. Campochiaro,et al.  Retina-specific expression of PDGF-B versus PDGF-A: vascular versus nonvascular proliferative retinopathy. , 2002, Investigative ophthalmology & visual science.

[11]  R. W. Allinson.  Adjuvant 5-FU and heparin prevent PVR. , 2002, Ophthalmology.

[12]  Xiaoxin Li,et al.  [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy]. , 2002, [Zhonghua yan ke za zhi] Chinese journal of ophthalmology.

[13]  S. Murota,et al.  Induction of hepatocyte growth factor (HGF) in rat microglial cells by prostaglandin E2 , 2000, Journal of neuroscience research.

[14]  J. A. Hunt,et al.  Active scatter factor (HGF/SF) in proliferative vitreoretinal disease. , 2000, Investigative ophthalmology & visual science.

[15]  Y. Ikuno,et al.  Attenuation of experimental proliferative vitreoretinopathy by inhibiting the platelet-derived growth factor receptor. , 2000, Investigative ophthalmology & visual science.

[16]  D. Brigstock,et al.  Connective tissue growth factor: what's in a name? , 2000, Molecular genetics and metabolism.

[17]  C. Pournaras,et al.  TGF-beta1, TGF-beta receptor II and ED-A fibronectin expression in myofibroblast of vitreoretinopathy. , 2000, Investigative ophthalmology & visual science.

[18]  M. Refojo,et al.  Platelet-derived growth factor plays a key role in proliferative vitreoretinopathy. , 1999, Investigative ophthalmology & visual science.

[19]  D. Brigstock.  The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family. , 1999, Endocrine reviews.

[20]  N. Mulder,et al.  Effects of peripheral stem-cell or bone-marrow reinfusion on peripheral serotonin metabolism , 1999, The Lancet.

[21]  P. Wiedemann,et al.  Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group. , 1998, American journal of ophthalmology.

[22]  C. Heldin,et al.  Signal transduction via platelet-derived growth factor receptors. , 1998, Biochimica et biophysica acta.

[23]  D. Hinton,et al.  Retinal pigment epithelial cells secrete and respond to hepatocyte growth factor. , 1998, Biochemical and biophysical research communications.

[24]  J. Duffy,et al.  Platelet derived growth factor and fibroblast growth factor basic levels in the vitreous of patients with vitreoretinal disorders , 1998, The British journal of ophthalmology.

[25]  D. Charteris.  Growth factors in proliferative vitreoretinopathy , 1998, The British journal of ophthalmology.

[26]  J. Rubin,et al.  Hepatocyte growth factor (HGF/SF) in Alzheimer's disease , 1998, Brain Research.

[27]  K. Matsumoto,et al.  Emerging multipotent aspects of hepatocyte growth factor. , 1996, Journal of biochemistry.

[28]  G. Michalopoulos,et al.  The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis , 1995, The Journal of cell biology.

[29]  P. Boros,et al.  Hepatocyte growth factor: a multifunctional cytokine , 1995, The Lancet.

[30]  J. Robertson,et al.  Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases. , 1994, Investigative ophthalmology & visual science.

[31]  J. Gérard,et al.  Radiation therapy in proliferative vitreoretinopathy , 1994, Graefe's Archive for Clinical and Experimental Ophthalmology.

[32]  S. Wu,et al.  Expression of growth factor mRNA in rabbit PVR model systems. , 1992, Current eye research.

[33]  G. Michalopoulos,et al.  Hepatocyte growth factor , 1992, Hepatology.

[34]  P. Wiedemann,et al.  Mononukleäre Phagozyten und ihre Wachstumsfaktoren: Schrittmacher der proliferativen Vitreoretinopathie? , 1990 .

[35]  J. H. Yeo,et al.  Oral colchicine for the treatment of experimental traction retinal detachment. , 1986, Archives of ophthalmology.

[36]  I. Constable,et al.  Taxol for the treatment of proliferative vitreoretinopathy. , 1985, Investigative ophthalmology & visual science.

[37]  R. Machemer,et al.  The classification of retinal detachment with proliferative vitreoretinopathy. , 1983, Ophthalmology.

[38]  Moore Rf.  THE COMPARATIVE VALUE OF COCAIN SUBSTITUTES. , 1924 .

[39]  You-xin Chen,et al.  Hepatocyte growth factor and its role in the pathogenesis of retinal detachment. , 2004, Investigative ophthalmology & visual science.

[40]  M. Shah,et al.  An immunohistochemical study , 2003 .

[41]  D. Brigstock,et al.  Immunohistochemical localization of connective tissue growth factor (CTGF) in the mouse embryo between days 7.5 and 14.5 of gestation. , 1999, Growth factors.

[42]  N. Rahimi,et al.  Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy. , 1999, Investigative ophthalmology & visual science.

[43]  S. Rosenkranz,et al.  Evidence for distinct signaling properties and biological responses induced by the PDGF receptor alpha and beta subtypes. , 1999, Growth factors.

[44]  Z. Gregor,et al.  Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. , 1993, Ophthalmology.

[45]  J. Garcia-Arumi,et al.  Subretinal membranes in proliferative vitreoretinopathy. An immunohistochemical study. , 1992, Retina.

[46]  Z. Gregor,et al.  Cellular components of subretinal membranes in proliferative vitreoretinopathy , 1989, Eye.